Since ANO1-specific blocker reduced the proliferation of cultured cancer cells (CFPAC-1, SCC1, T24, etc.)7,9,12, development of more specific and more potent ANO1 inhibitors will be useful for cancer therapy. The gene discussed is ANO1; the disease is cancer.